Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

In “Cerebral Entanglements,” Allan J. Hamilton argues that new imaging technologies give us unprecedented access — with revolutionary implications. By Deborah Blum “Saturday Night Live ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Google released Gemini 2.0 Flash for Google AI Studio and Vertex AI. The “Flash” in this model’s name means that it’s a model focused on speed. You’ll want to use this model if you want ...

Images, and the devices that capture them, are my focus. I've covered cameras at PCMag for the past 13 years, which has given me a front row seat for the DSLR to mirrorless transition, the ...

The Shark Vertex Pro IZ662H is part of the Vacuum Cleaners test program at Consumer Reports. In our lab tests, Stick Vacuums (Cordless) models like the Vertex Pro IZ662H are rated on multiple ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Every Friday, be the first to see reviews, news and features in The New York Times Book Review.

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...